The Life ILS Conference returns to London on Tuesday, May 21st , 2024. Hosted by Life Risk News, this must-attend conference will bring industry peers together to cover the latest market insights, news and trends in the Life ILS space.
The in person conference is planned to be held over a full-day at EY’s Canary Wharf offices in London, UK. We will also be providing a virtual broadcast option to those unable to attend in person.
– Exploring how the life risk markets introduce a global potential, forecasting a surge in demand and innovation.
– Unpacking the emergence of new possibilities for transferring longevity and mortality risk and leveraging secondary markets to foster extra liquidity.
– Delving deep into the effects of varying mortality rates among distinct groups.
– Engaging in discussions on the enduring resilience of the longevity and mortality risk markets in the face of economic fluctuations and unpredictable variables.
We are also excited to offer a number of sponsorship opportunities to help you showcase your firm, build new relationships and develop your brand recognition. Put your business in the spotlight and engage and interact with the Life ILS industry at this unique event. For more details reach out to the conference facilitator.
I hope you will join us physically or virtually on Tuesday May 21st. If you have any questions please do not hesitate to reach out to ELSA at email@example.com.
Please note due to capacity restrictions, outside of ELSA’s control, registration spaces in London will be allocated on a first come, first serve basis. In addition, in the event that the physical venues are required to be cancelled or have their capacity reduced ELSA will endeavor to host the conference virtually.
The conference was planned to be held over a full-day at EY’s Canary Wharf offices in London, UK.
We brought over 210 market participants together for an insightful day of Life ILS content and networking opportunities.
The Life ILS conference brought a range of speakers together to present on the future of mortality and longevity risk.